Background HIV-1 infection persists in reservoirs and leads to progressive depletion of CD4+ T-cells even in subjects with slow disease progression HIV-specific CD4+ T-cells are preferentially infected, while CMV-specific CD4+ T-cells are protected from infection in vivo Memory CD4+ T-cells expressing the gut-homing marker CCR6 are major sites for HIV-DNA integration in vivo Recruitment in excess of effector CD8+ T-cells in the proximity of target CD4+ T-cells is critical for the control of viral replication and disease progression Methods CFSE dilution assay was used to identify HIV- vs. CMV-specific T-cells Polychromatic flow cytometry was used to quantify expression of the gut- homing markers integrin β7, CCR6, and CXCR3 on proliferating T-cells ATRA and the inhibitor LE450 were used to determine the role of RA pathway in regulating expression of gut-homing molecules on HIV-specific T-cells Studies were performed on PBMC from HIV-infected subjects with a history of slow disease progression (n=5): median CD4 counts of 670 cells/µl, median plasma viral load of 964 HIV-RNA copies/ml, and median time since infection of 15 years Wacleche et al. Poster # TUPDA0101 Wacleche et al, PLoS One 2012 Goal: to investigate the co-localization potential of HIV-specific CD8+ and CD4+ T-cells into the gut-associated lymphoid tissues (GALT) and explore the role of retinoic acid (RA) in regulating this process
Results Wacleche et al, PLoS One 2012 ATRA upregulates integrin β7 but not CCR6 expression on HIV-specific CD4+ and CD8+ T-cells p=0.04 p=0.01 p=0.03 p= CD4+CD8+ CD4+CD8+ Expression of the gut homing markers integrin β7, CCR6 and CXCR3 represents a « signature » for HIV-specific CD4+ T-cells p=0.003 p=0.05 p=0.003 p= p= NS HIV-specific CD8+ vs CD4+ T-cells express higher, lower, and similar levels of integrin β7, CCR6, and CXCR3, respectively
Wacleche et al, PLoS One 2012 Proposed Model Acknowledgements Authors: Vanessa Wacleche, Nicolas Chomont, Annie Gosselin, Patricia Monteiro, Mathieu Goupil, Hassen Kared, Cécile Tremblay, Nicole Bernard, Mohamed-Rachid Boulassel, Jean-Pierre Routy, and Petronela Ancuta Financial support: CIHR, FRSQ, Fondation du CHUM, INSERM and ANRS HIV cohorts: FRSQ-SIDA Infectious Diseases Network; HIV-infected subjects